Is igA anticardiolipin antibody associated with the extent of daily-life ischaemia in patients with chronic coronary artery disease?
Increasing IgA-aCL levels are associated with increasing ischemic burden in patients with CAD.
Overall results determined that there is a need for screening for type 2 diabetes in a seventh-grade population.